What exists today
Open‑access clinical studies include:
- Randomized controlled trials in healthy adults and athletic performance settings.
- Open‑label pilots in rheumatoid arthritis and myopathy cohorts.
- Condition‑specific trials in radiotherapy quality of life, metabolic syndrome, and chronic hepatitis B.
These trials are real and worth tracking. They also tend to be small, often exploratory, and not yet decisive for broad health claims.
Common outcomes reported
- Changes in oxidative stress or inflammatory markers.
- Performance or fatigue recovery metrics in athletic cohorts.
- Patient‑reported outcomes such as quality of life.
Interpreting the findings responsibly
- A statistically significant change is not the same as a universal health outcome.
- Small sample sizes limit how far results can be generalized.
- Different preparation methods (electrolyzed, dissolved hydrogen, tablets) may not be equivalent.
What would strengthen the evidence base
- Larger, multi‑center randomized trials.
- Clear replication across different labs.
- Transparent reporting of water preparation and dosing.
The archive tracks each clinical study with provenance so readers can audit the underlying data.